Filing Flows

Filing Flows › CG Oncology (CGON) › Who owns the stock

Who owns CG Oncology (CGON) stock

217 funds reported CG Oncology (CGON) shares in their latest 13F filings, worth $6.9B in all. The largest holder is RTW Investments, LP ($605M). Last quarter 113 funds added to their stakes and 100 cut them.

Largest holders of CGON (13F)Largest holders of CGON (13F)RTW Investments, LP$605MT. Rowe Price Investment Manageme…$470MDecheng Capital LLC$453MBlackRock$445MWellington Management Group LLP$378MFMR LLC$296MVanguard Group$272MPrice T Rowe Associates$270MTCG Crossover Management, LLC$261MVanguard Portfolio Management LLC$246M

Largest holders (13F)

FundSharesValueChangeQuarter
RTW Investments, LP8,514,590$605Mincrease2026-06-30
T. Rowe Price Investment Management6,616,899$470Mdecrease2026-06-30
Decheng Capital LLC6,371,669$453Munchanged2026-06-30
BlackRock6,256,288$445Mincrease2026-06-30
Wellington Management Group LLP5,324,751$378Mdecrease2026-06-30
FMR LLC4,161,493$296Mincrease2026-06-30
Vanguard Group6,539,482$272Mdecrease2025-12-31
Price T Rowe Associates3,805,010$270Mincrease2026-06-30
TCG Crossover Management, LLC3,670,206$261Munchanged2026-06-30
Vanguard Portfolio Management LLC3,465,197$246Mincrease2026-06-30
State Street3,437,590$244Mincrease2026-06-30
Vanguard Capital Management LLC3,316,793$236Mincrease2026-06-30
Foresite Capital Management VI LLC2,369,574$168Mincrease2026-06-30
Geode Capital Management, LLC2,153,277$153Mincrease2026-06-30
Seven Fleet Capital Management LP1,886,236$134Mincrease2026-06-30

CG Oncology's latest quarter

CG Oncology, Q3 2026: revenue $1.6M (-4% year over year), net loss $56.9M, operating cash flow −$47.7M. The chart follows the revenue to costs, profit and cash.

Questions

Who owns the most CGON stock?

By the latest 13F filings: RTW Investments, LP ($605M); T. Rowe Price Investment Management ($470M); Decheng Capital LLC ($453M); BlackRock ($445M); Wellington Management Group LLP ($378M).

What is the short interest in CGON?

8,873,120 shares were sold short at the 2026-10-15 settlement, -15.02% of the float.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.